NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 977 coverALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY Copyright © 2002 by the New York Academy of Sciences
description

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by TOWNSEND, K. P.
Articles by MULLAN, M.
Search for Related Content
PubMed
PubMed Citation
Articles by TOWNSEND, K. P.
Articles by MULLAN, M.
Annals of the New York Academy of Sciences 977:65-76 (2002)
© 2002 New York Academy of Sciences

Proinflammatory and Vasoactive Effects of Aß in the Cerebrovasculature

K. P. TOWNSEND, D. OBREGON, A. QUADROS, N. PATEL, Ch. VOLMAR, D. PARIS AND M. MULLAN

Department of Psychiatry, Roskamp Institute, University of South Florida, Tampa, Florida 33613, USA

Address for correspondence: D. Paris. Department of Psychiatry, Roskamp Institute, University of South Florida, 3515 E. Fletcher Avenue, Tampa, FL 33613. Voice: 813-974-3722; fax: 813-974-3915.
dparis{at}hsc.usf.edu
Ann. N.Y. Acad. Sci. 977: 65-76 (2002).

Aß peptides are thought to be critical molecules in the pathophysiology of Alzheimer's disease (AD) and are the major protein constituents of senile plaques. In most AD cases, Aß peptides also form some deposits in the cerebrovasculature, leading to cerebral amyloid angiopathy and hemorrhagic stroke. Regional cerebral hypoperfusion is one of the earlier clinical manifestations in both the sporadic and familial forms of AD. In addition, a variety of vascular risk factors of different etiologies (for instance, diabetes, hypertension, high cholesterol level, atherosclerosis, and smoking) constitute risk factors for AD as well, suggesting that functional vascular abnormalities may contribute to AD pathology. We studied the effect of Aß on constrictor responses elicited by endothelin-1 in isolated human cerebral arteries collected following rapid autopsies. We report that freshly solubilized Aß potentiates endothelin-1-induced vasoconstriction in isolated human middle cerebral and basilar arteries. The vasoconstriction elicited by Aß in these large human cerebral arteries appears to be completely antagonized by NS-398, a selective cyclooxygenase-2 inhibitor, or by SB202190, a specific p38 mitogen-activated protein kinase inhibitor, suggesting that Aß vasoactivity is mediated via the stimulation of a proinflammatory pathway. In addition, a similar proinflammatory response appears to be mediated by Aß in isolated human brain microvessels, resulting in an increased production of prostaglandin E2 and F2{alpha}. Using a scanner laser Doppler imager, we show a progressive decline with aging in cortical perfusion level in transgenic APPsw mice (line 2576) compared with age-matched control littermates. The relation between the acute proinflammatory and vasoactive properties of Aß and the chronic progressive hypoperfusion seen in AD (and transgenic models thereof) is yet to be elucidated.

Key Words: ß-amyloid peptide (Aß) • Alzheimer's disease • cerebrovasculature • proinflammatory • vasoactivity • COX-2 inhibitor • mutant APP




This article has been cited by other articles:


Home page
BrainHome page
N.-W. Hu, I. M. Smith, D. M. Walsh, and M. J. Rowan
Soluble amyloid-{beta} peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo
Brain, August 4, 2008; (2008) awn174v1.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Maier, T. J. Seabrook, N. D. Lazo, L. Jiang, P. Das, C. Janus, and C. A. Lemere
Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.
J. Neurosci., May 3, 2006; 26(18): 4717 - 4728.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. A. Rippon, M. X. Tang, J. H. Lee, R. Lantigua, M. Medrano, and R. Mayeux
Familial Alzheimer disease in Latinos: Interaction between APOE, stroke, and estrogen replacement
Neurology, January 10, 2006; 66(1): 35 - 40.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. H. Reddy, S. McWeeney, B. S. Park, M. Manczak, R. V. Gutala, D. Partovi, Y. Jung, V. Yau, R. Searles, M. Mori, et al.
Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease
Hum. Mol. Genet., June 15, 2004; 13(12): 1225 - 1240.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. Beckmann, A. Schuler, T. Mueggler, E. P. Meyer, K.-H. Wiederhold, M. Staufenbiel, and T. Krucker
Age-Dependent Cerebrovascular Abnormalities and Blood Flow Disturbances in APP23 Mice Modeling Alzheimer's Disease
J. Neurosci., September 17, 2003; 23(24): 8453 - 8459.
[Abstract] [Full Text] [PDF]



footerLeft footerRight